Denali Therapeutics Inc. (DNLI)

NASDAQ: DNLI · IEX Real-Time Price · USD

17.14

0.00 (0.00%)

At close: May 6, 2024, 4:00 PM

17.29

+0.15 (0.88%)

After-hours: May 6, 2024, 7:38 PM EDT

Denali Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	127.11	218.04	293.48	507.14	79.45	77.12	218.38	39.85	30.74
Short-Term Investments	907.41	1,118	571.93	962.55	335.91	387.17	187.85	138.48	0
Cash & Cash Equivalents	1,035	1,336	865.41	1,470	415.36	464.3	406.23	178.33	30.74
Cash Growth	-22.58%	54.40%	-41.12%	253.84%	-10.54%	14.30%	127.79%	480.13%	-
Other Current Assets	29.63	36.1	31.83	25.96	14.68	16.54	3.38	3.62	2.69
Total Current Assets	1,064	1,372	897.23	1,496	430.03	480.84	409.61	181.96	33.43
Property, Plant & Equipment	71.64	74.52	69.61	73.46	80.66	25.16	14.92	15.26	3.17
Long-Term Investments	0	0	425.45	32.7	39.89	147.88	60.75	72.58	0
Other Long-Term Assets	18.14	13.4	11.87	2.46	2.66	8.11	1.44	1.27	0.08
Total Long-Term Assets	89.78	87.92	506.93	108.63	123.2	181.15	77.11	89.11	3.25
Total Assets	1,154	1,460	1,404	1,604	553.23	661.98	486.72	271.07	36.68
Accounts Payable	9.48	2.79	4.78	1.07	2.59	1.89	2.72	1.96	1.71
Deferred Revenue	0	0	0	0	0	35.96	6.29	0	0
Other Current Liabilities	68.5	361.13	373.47	70.63	42.75	-5.06	5.15	7.14	1.77
Total Current Liabilities	77.98	363.92	378.25	71.7	45.34	32.79	14.16	9.11	3.48
Long-Term Debt	44.98	53.03	58.55	64.18	68.87	0	0	0	0
Other Long-Term Liabilities	0	0.86	5.07	317.88	44.13	82.35	6.76	7.44	0.53
Total Long-Term Liabilities	44.98	53.89	63.63	382.05	113	82.35	6.76	7.44	0.53
Total Liabilities	122.96	417.81	441.87	453.75	158.34	115.14	20.93	16.55	4.01
Total Debt	44.98	53.03	58.55	64.18	68.87	0	0	0	0
Debt Growth	-15.18%	-9.43%	-8.76%	-6.81%	-	-	-	-	-
Retained Earnings	-1,116.21	-970.99	-645	-354.42	-425.55	-227.94	-191.7	-103.51	-16.86
Comprehensive Income	0.64	-6.89	-2.5	-0.25	0.35	-0.65	-0.37	-0.37	0
Shareholders' Equity	1,031	1,042	962.29	1,151	394.89	546.85	465.8	-94.15	-15.63
Net Cash / Debt	989.53	1,283	806.85	1,406	346.49	464.3	406.23	178.33	30.74
Net Cash / Debt Growth	-22.88%	59.04%	-42.59%	305.64%	-25.37%	14.30%	127.79%	480.13%	-
Net Cash Per Share	7.20	10.22	6.64	-	3.62	5.01	27.15	27.76	10.22
Working Capital	986.16	1,008	518.99	1,424	384.69	448.05	395.44	172.85	29.95
Book Value Per Share	7.50	8.30	7.92	9.59	4.13	5.90	31.13	-14.65	-5.20

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).